Skip to main content
Journal cover image

Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome

Publication ,  Journal Article
Silva, GM; Netto, LES; Discola, KF; Piassa‐Filho, GM; Pimenta, DC; Bárcena, JA; Demasi, M
Published in: The FEBS Journal
June 2008

The yeast 20S proteasome is subject to sulfhydryl redox alterations, such as the oxidation of cysteine residues (Cys‐SH) into cysteine sulfenic acid (Cys‐SOH), followed by S‐glutathionylation (Cys‐S‐SG). Proteasome S‐glutathionylation promotes partial loss of chymotrypsin‐like activity and post‐acidic cleavage without alteration of the trypsin‐like proteasomal activity. Here we show that the 20S proteasome purified from stationary‐phase cells was natively S‐glutathionylated. Moreover, recombinant glutaredoxin 2 removes glutathione from natively orS‐glutathionylated 20S proteasome, allowing the recovery of chymotrypsin‐like activity and post‐acidic cleavage. Glutaredoxin 2 deglutathionylase activity was dependent on its entry into the core particle, as demonstrated by stimulating S‐glutathionylated proteasome opening. Under these conditions, deglutathionylation of the 20S proteasome and glutaredoxin 2 degradation were increased when compared to non‐stimulated samples. Glutaredoxin 2 fragmentation by the 20S proteasome was evaluated by SDS–PAGE and mass spectrometry, and S‐glutathionylation was evaluated by either western blot analyses with anti‐glutathione IgG or by spectrophotometry with the thiol reactant 7‐chloro‐4‐nitrobenzo‐2‐oxa‐1,3‐diazole. It was also observedthat glutaredoxin 2 was ubiquitinated in cellular extracts of yeast cells grown in glucose‐containing medium. Other cytoplasmic oxido‐reductases, namely thioredoxins 1 and 2, were also active in 20S proteasome deglutathionylation by a similar mechanism. These results indicate for the first time that 20S proteasome cysteinyl redox modification is a regulated mechanism coupled to enzymatic deglutathionylase activity.

Duke Scholars

Published In

The FEBS Journal

DOI

EISSN

1742-4658

ISSN

1742-464X

Publication Date

June 2008

Volume

275

Issue

11

Start / End Page

2942 / 2955

Publisher

Wiley

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3404 Medicinal and biomolecular chemistry
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology
  • 1101 Medical Biochemistry and Metabolomics
  • 0601 Biochemistry and Cell Biology
  • 0304 Medicinal and Biomolecular Chemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Silva, G. M., Netto, L. E. S., Discola, K. F., Piassa‐Filho, G. M., Pimenta, D. C., Bárcena, J. A., & Demasi, M. (2008). Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome. The FEBS Journal, 275(11), 2942–2955. https://doi.org/10.1111/j.1742-4658.2008.06441.x
Silva, Gustavo M., Luis E. S. Netto, Karen F. Discola, Gilberto M. Piassa‐Filho, Daniel C. Pimenta, José A. Bárcena, and Marilene Demasi. “Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome.” The FEBS Journal 275, no. 11 (June 2008): 2942–55. https://doi.org/10.1111/j.1742-4658.2008.06441.x.
Silva GM, Netto LES, Discola KF, Piassa‐Filho GM, Pimenta DC, Bárcena JA, et al. Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome. The FEBS Journal. 2008 Jun;275(11):2942–55.
Silva, Gustavo M., et al. “Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome.” The FEBS Journal, vol. 275, no. 11, Wiley, June 2008, pp. 2942–55. Crossref, doi:10.1111/j.1742-4658.2008.06441.x.
Silva GM, Netto LES, Discola KF, Piassa‐Filho GM, Pimenta DC, Bárcena JA, Demasi M. Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl‐based redox modification of the 20S proteasome. The FEBS Journal. Wiley; 2008 Jun;275(11):2942–2955.
Journal cover image

Published In

The FEBS Journal

DOI

EISSN

1742-4658

ISSN

1742-464X

Publication Date

June 2008

Volume

275

Issue

11

Start / End Page

2942 / 2955

Publisher

Wiley

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3404 Medicinal and biomolecular chemistry
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology
  • 1101 Medical Biochemistry and Metabolomics
  • 0601 Biochemistry and Cell Biology
  • 0304 Medicinal and Biomolecular Chemistry